Evaluation of Tirzepatide as an Adjunct to Buprenorphine for the Treatment of Opioid Use Disorder

Recruiting

Phase 2

TirzepatideEvaluation of Tirzepatide as an Adjunct to Buprenorphine for the Treatment of Opioid Use Disorder

Sponsor:

T. John Winhusen, PhD

Code:

NCT06651177

Conditions

Opioid Use Disorder

Opioid Use Disorder, Moderate

Opioid Use Disorder, Severe

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

Tirzepatide

Placebo

Study Details

Eligibility Criteria

Study Design

Interventions and Outcome Measures

Central Contacts and Locations

More Information

Trial information was received from ClinicalTrials.gov and was last updated on 2026-01-10. This information was provided to ClinicalTrials.gov by T. John Winhusen, PhD on 2025-12-18.